DrMedHealth Review
Best for: Cost-conscious patients seeking low-priced compounded GLP-1s from a LegitScript-certified clinic.
DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss. Board-certified physicians prescribe compounded semaglutide from $199/mo and compounded tirzepatide from $299/mo, with FDA-approved branded options (Ozempic, Wegovy, Mounjaro) also available. The platform advertises roughly 2-hour physician review and free shipping, with compounded medication prepared by licensed US pharmacies. It operates across many states via state-specific pages (California, Michigan, Indiana, Utah and others). Compounded GLP-1s are not FDA-approved for quality, safety or efficacy.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
DrMedHealth is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
DrMedHealth prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| starting | compounded | $199 |
| starting | compounded | $299 |
✓ Pros
- •LegitScript certified telehealth platform
- •Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
- •Both compounded and FDA-approved branded options available
- •Fast physician review (advertised ~2 hours) with free shipping
- •Compounded by licensed US pharmacies
- •Operates across many states with dedicated state pages
✗ Cons
- •Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
- •Cash-pay model; insurance generally not accepted for medication
- •Full list of available states not consolidated in one place
- •Site is JavaScript-rendered, limiting easy review of full terms
Ready to start with DrMedHealth?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our DrMedHealth review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to DrMedHealth
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with DrMedHealth?
Starting at $199/month. See current pricing and start your free consultation.